VIDEO: New indications for JAK inhibitors advance field

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

It is an interesting question because in that time period of transition from training to an attending, but I think that the thing that's most notable is seeing all the new indications that are coming out for JAK inhibitors. You know, so as a rheumatologist, particularly relevant to us is, of course, ankylosing spondylitis. But there's other diseases that also impact us a lot as well, such as inflammatory bowel disease, indications for Crohn's and ulcerative colitis. We're seeing new indications for atopic dermatitis, so eczema, even vitiligo. So there's just a wealth of conditions that JAK inhibitors are now being FDA approved for.